Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |